145 related articles for article (PubMed ID: 22195061)
1. Automated plan-recognition of chemotherapy protocols.
Bhatia H; Levy M
AMIA Annu Symp Proc; 2011; 2011():108-14. PubMed ID: 22195061
[TBL] [Abstract][Full Text] [Related]
2. Dose intensity in cancer chemotherapy.
Dodwell DJ; Gurney H; Thatcher N
Br J Cancer; 1990 Jun; 61(6):789-94. PubMed ID: 2164831
[No Abstract] [Full Text] [Related]
3. Chemotherapy principles for breast, prostate, colon and lung cancer.
Keppen M
S D Med; 2010; Spec No():52-6. PubMed ID: 20397492
[No Abstract] [Full Text] [Related]
4. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
[TBL] [Abstract][Full Text] [Related]
5. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastasized breast cancer].
Thurm K
Z Erkr Atmungsorgane; 1986; 166(1):112-5. PubMed ID: 3953107
[TBL] [Abstract][Full Text] [Related]
7. [A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy].
Yoshino H; Kinoshita S; Emori N; Kadoya S; Hiranuma C; Ishiguro K; Koizumi H; Morita K; Bando H; Murakami N; Yamada T
Gan To Kagaku Ryoho; 2006 Mar; 33(3):365-7. PubMed ID: 16531720
[TBL] [Abstract][Full Text] [Related]
8. Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.
Baker K; Dunwoodie E; Jones RG; Newsham A; Johnson O; Price CP; Wolstenholme J; Leal J; McGinley P; Twelves C; Hall G
Int J Med Inform; 2017 Jul; 103():32-41. PubMed ID: 28550999
[TBL] [Abstract][Full Text] [Related]
9. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
10. [Complete regression of breast cancer and its lung metastases after chemohormonotherapy].
Borisov VI; Vorob'ev AN; Stsetsevich NV; Ass NIa
Sov Med; 1986; (12):123-4. PubMed ID: 3563699
[No Abstract] [Full Text] [Related]
11. [A case of advanced breast cancer with multiple lung metastases responding well to postoperative combined administration of doxifluridine (5'-DFUR) and tamoxifen].
Tohma H; Noshiro H; Hachiya Y; Akashi Y; Miyoshi A
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1267-9. PubMed ID: 8031170
[TBL] [Abstract][Full Text] [Related]
12. [The clinical course and treatment results of lung metastases from breast cancer].
Xu B; Zhou J; Zhou A
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):274-6. PubMed ID: 11038757
[TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial infusion chemotherapy for breast cancer].
Tokura H; Ikeda T; Kitajima M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):176-81. PubMed ID: 11865621
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary tuberculosis in a patient receiving intensive chemotherapy for metastatic breast cancer.
Ito K; Fujimori M; Shingu K; Hama Y; Kanai T; Koyama H; Amano J
Breast J; 2005; 11(1):87-8. PubMed ID: 15647091
[No Abstract] [Full Text] [Related]
15. [A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
Ishii K; Tsugawa K; Nakamura M; Ohnishi I; Miwa K
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2133-6. PubMed ID: 14712778
[TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of newer regimens for the prophylaxis of chemotherapy-induced nausea and vomiting: review of the literature and real-world data.
Giuliani J; Bonetti A
Curr Opin Oncol; 2020 Jul; 32(4):269-273. PubMed ID: 32541312
[TBL] [Abstract][Full Text] [Related]
18. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Shaw GL; Gazdar AF; Phelps R; Steinberg SM; Linnoila RI; Johnson BE; Oie HK; Russell EK; Ghosh BC; Pass HI; Minna JD; Mulshine JL; Ihde DC
J Cell Biochem Suppl; 1996; 24():173-85. PubMed ID: 8806100
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
[TBL] [Abstract][Full Text] [Related]
20. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
